Practical, step-by-step guides for anyone starting or managing GLP-1 treatment. Learn how to begin safely, what to expect week by week, and how to get the most from your medication with confidence.
Patient Guides
A tragic inquest into the death of a London law student has renewed scrutiny around unsupervised weight loss drug use. This article breaks down what GLP-1 users need to know about safe use, red flags to watch for, and why medical oversight matters.
Actress Chrissy Metz recently revealed she's taking a GLP-1 medication after being "very skeptical" about the drug class. Her story reflects what millions of people considering semaglutide or tirzepatide experience before starting treatment. We break down what that skepticism usually comes from and how to decide if GLP-1s are right for you.
Most people who stop taking GLP-1 medications regain a significant portion of their lost weight within months. This article explains what happens in your body when you stop, why it happens, and what you can do about it. Whether you're pausing due to cost, side effects, or supply issues, this guide helps you plan smarter.
Emerging evidence suggests GLP-1 receptor agonists may reduce the risk of major adverse cardiovascular events (MACE) in high-risk patients. This article breaks down what the research means, who stands to benefit most, and how this could influence your treatment decisions.
Eli Lilly reported a massive 48% revenue jump, driven almost entirely by Mounjaro and Zepbound. For patients already on these medications or considering them, this growth signals important shifts in supply, pricing, and access worth understanding before your next prescription decision.
Eli Lilly recently beat earnings estimates on strong demand for its injectable GLP-1 drugs, widening its lead over Novo Nordisk. For patients, this growing competition has real implications for drug availability, pricing, and future treatment options. Here's what you need to know.
Emerging research suggests GLP-1 receptor agonists like semaglutide and tirzepatide may reduce fracture risk in adults with type 2 diabetes, adding to their growing list of health benefits. This article breaks down what the science says, why it matters for patients, and what to discuss with your doctor before starting treatment.
Semaglutide medications like Ozempic are powerful tools for weight loss, but they have real limitations that many patients don't hear about upfront. This article breaks down what GLP-1 drugs can't fix on their own, from muscle loss to emotional eating patterns, and what you can do about it. Understanding the full picture helps you set realistic expectations and build a plan that actually lasts.
